Kalexsyn Inc.'s leadership has been recognized for promoting excellence in technology.
David Zimmermann, CEO, and Robert Gadwood, Ph.D., president and chief scientific officer, of the company have been named Ernst & Young Entrepreneurs Of The Year.
The Kalamazoo-based company focuses on providing medicinal chemistry services to the pharmaceutical industry and has averaged 30 percent growth each year since its founding.
The award, in its 24th year, is given to entrepreneurs who demonstrate success in innovation, financial performance and personal commitment to their businesses and communities. Kalexsyn competed for the award with companies in Michigan and Northwest Ohio.
"These entrepreneur of the year award winners are best in class, and we are proud to honor their outstanding success," says Frank Maselli, Ernst & Young L.L.P.
Zimmermann and Gadwood founded Kalexsyn, a contract research organization, in 2003 with assistance from Southwest Michigan First, Western Michigan University and the Michigan Economic Development Corporation.
"This award recognizes the quality and value Kalexsyn brings to each of our clients," Zimmermann says. "Contract research organizations like ours thrive on the skills and qualities found in our exceptional staff and scientific team."
Kalexsyn is a world-class medicinal chemistry contract research organization (CRO). Its scientists average 15 years of experience in hit validation, lead optimization and solving tough synthetic problems. The company offers clients an outstanding CRO experience, including tailored short- and long-term FTE arrangements. Kalexsyn is privately owned and located in Kalamazoo, Michigan.
Writer: Kathy Jennings
Source: David Zimmermann, Kalexsyn Inc.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.